News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Melanie Darvish, BSN, RN

Advertisement

Articles by Melanie Darvish, BSN, RN

Melanie Darvish

Melanie Darvish on Receiving an ONS Scholarship and What it Means to Be An Oncology Nurse

ByMelanie Darvish, BSN, RN
May 12th 2023

Melanie Darvish, BSN, RN, shares her experience attending the Oncology Nursing Society (ONS) Congress with an ONS Scholarship.

Advertisement

Latest Updated Articles

  • Melanie Darvish
    Melanie Darvish on Receiving an ONS Scholarship and What it Means to Be An Oncology Nurse

    Published: May 12th 2023 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Race Identified as Prognostic Indicator in Black Patients With AML

2

FDA Approves Liso-Cel in Pretreated R/R Marginal Zone Lymphoma

3

Families of Children With ALL Face Extreme Financial Toxicity

4

Fixed-Duration Venetoclax Regimens Yield Noninferior CLL PFS to Ibrutinib

5

Real-World Elranatamab Maintains Responses in Elderly, Frail R/R Multiple Myeloma

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us